GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...

Widespread and accessible testing is an essential component of our nation’s response to the Covid-19 pandemic. Yet while testing continues to expand across the U.S., with nearly 90 million tests ...